CD-ROM

Tuberculosis

Presentation type		Track	Abstract category	Text
All Oral abstracts Poster Discussions Poster Exhibition CD-ROM		All A B C D	All Acute and early infection Acute and early infection and management of patients with acquired viral resistance Adherence in adults Adherence in children and adolescents Ageing AIDS related malignancies (KS, lymphoma, cervical and anal carcinoma) including HHV8 infection Animal Models Animal models of transmission, disease resistance and progression Antibody based vaccines Antiretroviral Therapies (strategic categories apply to resource rich and constrained settings) in Children and Adolescents Antiretroviral therapy,clinical trials and cohorts Antiretroviral treatment of people living with HIV for prevention Approaches to counselling and testing in children and caregivers Behavioural surveillance Bioinformatic analysis in drug resistance Bioinformatics analysis of viral diversity in natural history Blood, organ and tissue safety and nosocomial transmission Cellular immunity based vaccines Clinical trials Cohort studies Complementary and traditional medicines and the role of traditional healers in therapy Complications of Anti-Retroviral Therapy and Adherence in Adults and Children Correlates of immune protection Diagnosis of HIV disease Diagnostic Tools for the Immunological and Virological Monitoring of HIV Infection Disease burden – morbidity/mortality Epidemiology of HIV in people who use drugs Epidemiology of sexually transmitted infections (STI) and HIV Estimating the need for HIV treatment Estimating the size of HIV-infected and most at risk population Ethical issues in epidemiological research First line therapy Harm reduction, including reduction of unsafe injecting and other approaches Hepatitis co-infections: (including HBV, HCV) HIV counselling, testing and diagnostic strategies HIV diversity and epidemiology HIV Pathogenesis/Immune Function and Dysfunction HIV Pathogenesis/Latency and Viral Reservoirs HIV superinfections HIV Surveillance, Monitoring and Evaluation HIV tropism, dynamics and fitness HIV-1 and HIV-2 co-infections HIV-2 Host genetics of resistance and susceptibility Immune reconstitution disorders / IRIS Impact of nutrition Innate immunity responses and function in natural history of HIV infection Malaria Male and female condoms and other physical barriers Male circumcision Management of late presenters Measuring and modelling the effect and impact of other HIV prevention interventions Measuring and modelling the effect and impact of PMTCT Measuring and modelling the impact of the HIV epidemic Mechanisms of T cell depletion and dysfunction Methodological Issues and Capacity-Building in Epidemiology and Prevention Research Microbicides Monitoring and evaluation (other) Monitoring and evaluation of HIV prevention, care and treatment Mother to child transmission Mucosal immunity/defenses: responses and dysfunction Mucosal transmission Mycobacteria and TB Natural history, progression and survival Neurologic and psychiatric manifestations, including neurocognitive disorders New HIV testing and diagnostic strategies New monitoring strategies including rapid tests Non pathogenic models of SIV Non-AIDS related co-morbidities (e.g. diabetes, hypertension etc) Non-AIDS related malignancies Novel animal models for vaccine and inhibitor development Novel assays of immune responses Novel Treatment and Prevention Strategies Novel vectors and strategies Nucleic acid based HIV and SIV therapies Opportunistic infections (excluding mycobacterial) Other adverse reactions and complications of ARV therapy Other bacterial infections and malaria and parasitic infections Other complications Other Therapies Paediatric surveillance of HIV Pharmacogenomics Pharmacology, pharmacokinetics, drug formulations Population-based surveys with HIV testing Preclinical development of microbicides Pre-exposure and post-exposure prophylaxis Prevention addressing gender inequalities Prevention for men who have sex with men (MSM) Prevention for people living with HIV Prevention for people who use drugs Prevention for the general population Prevention in institutional settings e.g. workplace, school, prison, military Prevention of mother-to-child transmission Prophylaxis of HIV associated infections; vaccines e.g. pneumococcal, hepatitis and HPV, co-trimoxazole prophylaxis and IPT Research designs in epidemiology Sexually transmitted infections (STI) Simplification strategies (induction/maintenance and use of bPI monotherapy) STI prevention and control Surveillance of HIV (Youth and Adults) Surveillance systems and methods Switch studies Therapy for the heavily pre-treated patient Track B - Clinical Sciences Track C: Epidemiology and Prevention Sciences Transmission and Early Infection Tuberculosis Viral determinants of SIV pathogenesis Viral fitness and tropism assays, utility and application in clinical practice Viral resistance testing in clinical trials and practice Virus-specific cellular immunity When to start therapy
Late breakers only

Posters with this symbol have been selected by the Scientific Programme Committee for distinction based on merit.

Posters with this symbol have an e-Poster available.

CDB037 Abstract Interferon-γ release assays (IGRAs) for detection and treatment response of tuberculosis in patients with HIV infection I. Sauzullo1, F. Mengoni1, M. Lichtner2, J. Marafini2, R. Rossi1, P. Massetti1, V. Vullo1, C. Mastroianni2 1Sapienza University, Rome, Italy, 2Sapienza University, Latina, Italy CDB038 Abstract Neutrophil count and risk of tuberculosis in HIV-infected adults G. de Bruyn1, A. Martineau2, K. Fielding3, N. Tshabangu1, T. Modisenyane1, C. Ingram4, J. Golub5, R. Chaisson5, R. Wilkinson6,7, N. Martinson1,5 1Perinatal HIV Research Unit, Johannesburg, South Africa, 2Queen Mary`s School of Medicine and Dentistry, London, United Kingdom, 3London School Hygiene and Tropical Medicine, London, United Kingdom, 4Central Laboratory Services, Johannesburg, South Africa, 5Johns Hopkins University, Baltimore, United States, 6University of Cape Town, Cape Town, South Africa, 7Imperial College, London, United Kingdom CDB039 Abstract Tuberculosis (TB) and opportunistic diseases (OIs) at entry to HIV care in Rio de Janeiro, Brazil: The TB/HIV in Rio (THRio) Cohort V. Saraceni1, B. King2, S. Cavalcante1, J. Golub2, A. Pacheco1, L. Moulton3, A. Efron2, B. Durovni1, R. Chaisson2, THRio Study Group 1Secretariat de Saude, Rio de Janeiro, Brazil, 2Johns Hopkins School of Medicine, Baltimore, United States, 3Johns Hopkins Bloomberg School of Public Health, Baltimore, United States CDB040 Abstract Impact of previous ART and of ART initiation on outcome of HIV-associated TB E. Girardi1, P. Vanacore1, F. Palmieri1, C. Angeletti1, S. Carbonara2, G. Ippolito1 1National Institute of Infectious Diseases L. Spallanzani, Rome, Italy, 2University of Bari, Clinic of Infectious Diseases, Bari, Italy CDB041 Abstract Can antiretoviral therapy contain a previously escalating TB epidemic in a high HIV prevalence community? K. Middelkoop1, R. Wood1, L. Myer2,3, E. Sebastian4, L.-G. Bekker1 1University of Cape Town; Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine; Department of Medicine, Cape Town, South Africa, 2University of Cape Town, Infectious Diseases Epidemiology Unit, School of Public Health & Family Medicine, Cape Town, South Africa, 3Columbia University, Department of Epidemiology, Mailman School of Public Health, New York, United States, 4University of Cape Town; Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa CDB042 Abstract What is the causal effect of combination antiretroviral therapy on the incidence of tuberculosis among HIV-infected patients in Spain? J. Del Amo1, S. Pérez-Hoyos2, I. Jarrin1, M. Leal3, F. Gutierrez4, J. López-Aldeguer5, J.A. Iribarren6, F. Vidal7, M. Martinez-Pérez8, J.R. Blanco9, S. Moreno10, M. Hernan11, CoRIS-MD&CoRIS 1Instituto de Salud Carlos III, Madrid, Spain, National Center Epidemiology, Madrid, Spain, 2Hospital Clinic-IDIBAPS, Barcelona, Spain, 3Hospital Virgen del Rocio, Seville, Spain, 4Hospital Universitario Elche, Elche, Alicante, Spain, 5Hospital Universitario La Fe, Valencia, Spain, 6Hospital Donostia, San Sebastian, Spain, 7Hospital Universitario Joan XXIII, Tarragona, Spain, 8Hospital San Cecilio, Granada, Spain, 9Hospital San Pedro - CIBIR, Logroño, Spain, 10Hospital Ramon y Cajal, Madrid, Spain, 11Harvard School of Public Health, Boston, United States